TALS
Talaris Therapeutics Inc
$2.86
Earnings Summary
Net Profits | $-14.74Mn |
Highlights
Net Profits:
Talaris Therapeutics Inc’s net profit jumped 18.56% since last year same period to $-14.74Mn in the Q2 2023. On a quarterly growth basis, Talaris Therapeutics Inc has generated 29.54% jump in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Talaris Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.32 |
EPS Estimate Current Year | -0.32 |
Highlights
EPS Estimate Current Quarter:
Talaris Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.32 - a 26.15% jump from last quarter’s estimates.
EPS Estimate Current Year:
Talaris Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.32.
Key Ratios
Key ratios of the Talaris Therapeutics Inc post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Earning Per Share (EPS):
Talaris Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Talaris Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-10 | -0.32 | 0 | 100% |
2023-08-14 | -0.43 | 0 | 100% |
2023-05-15 | -0.55 | 0 | 100% |
₹0 US Stocks a/c Opening Fee